Evidence map›Paper›PMID 29123519›Full record

ArticleFrontiers in immunology2017

Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Maria Laura Costa, Michelle L Robinette, Mattia Bugatti, Mark S Longtine, Bryanne N Colvin, Erica Lantelme, William Vermi, Marco Colonna, D Michael Nelson, Marina Cella

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. The landscape of decidual immune cells at the maternal-fetal interface in parturition and preterm birth.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Modulatory Effects of Pregnancy on Inflammatory Bowel Disease.Clinical and translational gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Maria Laura CostaDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, United States.
Michelle L RobinetteDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.
Mattia BugattiDepartment of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy.
Mark S LongtineDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, United States.
Bryanne N ColvinDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, United States.
Erica LantelmeDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.
William VermiDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.
D Michael NelsonDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, United States.
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.
Washington University in St. Louis · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Brescia · IT

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
IL-22 IN OBESITY AND OBESITY-ASSOCIATED CANCERR01CA176695 · NCI · WASHINGTON UNIVERSITY · PI CELLA, MARINA · 2013 to 2017
$1.6M
NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA176695
6 · The paper itself

Abstract

During pregnancy, immune cells infiltrate the placenta at different stages of fetal development. NK cells and macrophages are the most predominant cell types. These immune cells play pleiotropic roles, as they control spiral artery remodeling to ensure appropriate blood supply and maintain long-term tolerance to a true allograft; yet, they must be able to mount appropriate immune defenses to pathogens that may threaten the fetus. Whether the same cell type accomplishes all these tasks or if there are dedicated subsets remains controversial. Here, we identify and characterize two distinct subsets of myeloid cells that differ in their pro-inflammatory/regulatory capacity. While one subset predominantly produces the immune-modulating cytokine IL-10, the second subset has superior capacity to secrete pro-inflammatory mediators, such as IL-1β and IL-6. The putative regulatory myeloid cells also express high levels of inhibitory receptors and their ligands, including programmed cell death 1 (PD1) ligands. Importantly, a large fraction of CD8 and CD4 cells in normal term human placenta are PD1 positive, suggesting that the PD1/PD1 ligands axis might be critical to maintain tolerance during pregnancy.

Indexed as

antigen-presenting cellsinflammationplacentapregnancytolerance

Identifiers

PMID29123519
PMCPMC5662895
OpenAlexW2766243764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.